William Blair & Company’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.9K | Hold |
|
|||||
|
2025
Q1 | $46.2K | Hold |
|
|||||
|
2024
Q4 | $48.9K | Hold |
|
|||||
|
2024
Q3 | $104K | Hold |
|
|||||
|
2024
Q2 | $85.6K | Hold |
|
|||||
|
2024
Q1 | $90.5K | Hold |
|
|||||
|
2023
Q4 | $62.9K | Hold |
|
|||||
|
2023
Q3 | $72.7K | Hold |
|
|||||
|
2023
Q2 | $54.6K | Hold |
|
|||||
|
2023
Q1 | $79.6K | Hold |
|
|||||
|
2022
Q4 | $42.8K | Sell |
|
|||||
|
2022
Q3 | $67K | Hold |
|
|||||
|
2022
Q2 | $54K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $42K | Hold |
|
|||||
|
2021
Q2 | $34K | Hold |
|
|||||
|
2021
Q1 | $23K | Hold |
|
|||||
|
2020
Q4 | $24K | Hold |
|
|||||
|
2020
Q3 | $29K | Hold |
|
|||||
|
2020
Q2 | $33K | Hold |
|
|||||
|
2020
Q1 | $21K | Sell |
|
|||||
|
2019
Q4 | $98K | Hold |
|
|||||
|
2019
Q3 | $125K | Buy |
|
|||||
|
2019
Q2 | $45K | Buy |
|